Projects per year
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Roberts, S. (Primary Chief Investigator (PCI))
3/03/25 → 2/03/27
Project: Research
-
A Phase 1, Open-Label, First-in-Human, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT 303 in Adults with Advanced or Metastatic GPC3-Expressing Cancers, including Hepatocellular Carcinoma
Roberts, S. (Primary Chief Investigator (PCI))
25/09/24 → 24/09/26
Project: Research
-
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF EFRUXIFERMIN IN SUBJECTS WITH COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS (NASH)/METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)
Roberts, S. (Primary Chief Investigator (PCI))
18/09/24 → 17/09/26
Project: Research
-
Comparison of Digitally Delivered Gut-Directed Hypnotherapy Program With an Active Control for Irritable Bowel Syndrome
Anderson, E. J., Peters, S. L., Gibson, P. R. & Halmos, E. P., Feb 2025, In: American Journal of Gastroenterology. 120, 2, p. 440-448 9 p.Research output: Contribution to journal › Article › Research › peer-review
3 Citations (Scopus) -
Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero
Prentice, R., Flanagan, E., Wright, E. K., Gibson, P. R., Rosella, S., Rosella, O., Begun, J., An, Y. K., Lawrance, I. C., Kamm, M. A., Sparrow, M., Goldberg, R., Prideaux, L., Vogrin, S., Kiburg, K. V., Ross, A. L., Burns, M. & Bell, S. J., Jan 2025, In: Clinical Gastroenterology and Hepatology. 23, 1, p. 124-133.e7 17 p.Research output: Contribution to journal › Article › Research › peer-review
3 Citations (Scopus) -
Application of a Precision-Dosing Model to a Real-World Cohort of Patients on Infliximab Maintenance Therapy: Drug Usage and Cost Analysis
Nguyen, A. L., Gibson, P. R., Upton, R. N., Mould, D. R. & Sparrow, M. P., Apr 2024, In: The Journal of Clinical Pharmacology. 64, 4, p. 399-409 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus)
Prizes
-
Fellow of the American Gastroenterology Association
Boussioutas, A. (Recipient), 2020
Prize: Election to learned society
-
Finalist for the Gastroenterological Society of Australia Young Investigator award
Yao, C. (Recipient), 2016
Prize: Prize (including medals and awards)
-
Gastroenterology Society of Australia
Boussioutas, A. (Recipient), 2022
Prize: Election to learned society
Activities
-
University of Manchester (External organisation)
Boussioutas, A. (Member)
2020Activity: Industry, Government and Philanthropy Engagement and Partnerships › Membership of an advisory panel/policy group/ board
-
Chair, Victorian Comprehensive Cancer Centre, Investigator Initiated Trial support program
Boussioutas, A. (Chair/ Co-Chair)
2019Activity: External Academic Engagement › Committees and working groups
-
Australian Red Cross Lifeblood (Victoria) (External organisation)
Boussioutas, A. (Member)
2019 → …Activity: Industry, Government and Philanthropy Engagement and Partnerships › Membership of an advisory panel/policy group/ board